These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 27491953)

  • 21. Risk factors associated with equine motor neuron disease: a possible model for human MND.
    Mohammed HO; Cummings JF; Divers TJ; Valentine B; de Lahunta A; Summers B; Farrow BR; Trembicki-Graves K; Mauskopf A
    Neurology; 1993 May; 43(5):966-71. PubMed ID: 8492954
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantitative assessment of motor neuron loss in equine motor neuron disease (EMND).
    Weber Polack E; King JM; Cummings JF; de Lahunta A; Divers TJ; Mohammed HO
    Equine Vet J; 1998 May; 30(3):256-9. PubMed ID: 9622328
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuroaxonal dystrophy associated with vitamin E deficiency in two Haflinger horses.
    Baumgärtner W; Frese K; Elmadfa I
    J Comp Pathol; 1990 Jul; 103(1):114-9. PubMed ID: 2394844
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evidence of the Primary Afferent Tracts Undergoing Neurodegeneration in Horses With Equine Degenerative Myeloencephalopathy Based on Calretinin Immunohistochemical Localization.
    Finno CJ; Valberg SJ; Shivers J; D'Almeida E; Armién AG
    Vet Pathol; 2016 Jan; 53(1):77-86. PubMed ID: 26253880
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Equine degenerative myeloencephalopathy.
    Miller MM; Collatos C
    Vet Clin North Am Equine Pract; 1997 Apr; 13(1):43-52. PubMed ID: 9106342
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasma and liver copper values in horses with equine degenerative myeloencephalopathy.
    Dill SG; Hintz HF; deLahunta A; Waldron CH
    Can J Vet Res; 1989 Jan; 53(1):29-32. PubMed ID: 2914224
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of feeding two RRR-α-tocopherol formulations on serum, cerebrospinal fluid and muscle α-tocopherol concentrations in horses with subclinical vitamin E deficiency.
    Brown JC; Valberg SJ; Hogg M; Finno CJ
    Equine Vet J; 2017 Nov; 49(6):753-758. PubMed ID: 28432750
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Equine Neuroaxonal Dystrophy and Degenerative Myeloencephalopathy.
    Finno CJ; Johnson AL
    Vet Clin North Am Equine Pract; 2022 Aug; 38(2):213-224. PubMed ID: 35811203
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lipid peroxidation biomarkers for evaluating oxidative stress in equine neuroaxonal dystrophy.
    Finno CJ; Estell KE; Winfield L; Katzman S; Bordbari MH; Burns EN; Miller AD; Puschner B; Tran CK; Xu L
    J Vet Intern Med; 2018 Sep; 32(5):1740-1747. PubMed ID: 30133798
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical, viral, and genetic evaluation of equine degenerative myeloencephalopathy in a family of Appaloosas.
    Blythe LL; Hultgren BD; Craig AM; Appell LH; Lassen ED; Mattson DE; Duffield D
    J Am Vet Med Assoc; 1991 Mar; 198(6):1005-13. PubMed ID: 2032902
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A case of equine motor neuron disease (EMND).
    Sasaki N; Yamada M; Morita Y; Furuoka H; Itoh M; Satoh M; Yamada H
    J Vet Med Sci; 2006 Dec; 68(12):1367-9. PubMed ID: 17213712
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Incidence and risk factors of equine motor neuron disease: an ambidirectional study.
    de la Rúa-Doménech R; Mohammed HO; Cummings JF; Divers TJ; de Lahunta A; Valentine B; Summers BA; Jackson CA
    Neuroepidemiology; 1995; 14(2):54-64. PubMed ID: 7891815
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Determination of vitamin E and its metabolites in equine urine using liquid chromatography-mass spectrometry.
    Favro G; Habib H; Gennity I; Puschner B; Hales EN; Finno CJ; Moeller BC
    Drug Test Anal; 2021 Jun; 13(6):1158-1168. PubMed ID: 33527764
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparing equine motor neuron disease (EMND) with equine grass sickness (EGS).
    Divers TJ
    Equine Vet J; 1999 Mar; 31(2):90-1. PubMed ID: 10213417
    [No Abstract]   [Full Text] [Related]  

  • 35. Differential expression of TAR DNA-binding protein (TDP-43) in the central nervous system of horses afflicted with equine motor neuron disease (EMND): a preliminary study of a potential pathologic marker.
    El-Assaad I; Di Bari JA; Yasuda K; Divers TJ; Summers BA; de Lahunta A; Mohammed H
    Vet Res Commun; 2012 Dec; 36(4):221-6. PubMed ID: 22918699
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genome-Wide Association Study and Subsequent Exclusion of
    Hales EN; Esparza C; Peng S; Dahlgren AR; Peterson JM; Miller AD; Finno CJ
    Genes (Basel); 2020 Jan; 11(1):. PubMed ID: 31936863
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Histopathologic findings in the sacrocaudalis dorsalis medialis muscle of horses with vitamin E-responsive muscle atrophy and weakness.
    Bedford HE; Valberg SJ; Firshman AM; Lucio M; Boyce MK; Trumble TN
    J Am Vet Med Assoc; 2013 Apr; 242(8):1127-37. PubMed ID: 23547678
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Equine motor neuron disease (EMND). A case report].
    Landolt G; Feige K; Grest P
    Tierarztl Prax; 1997 May; 25(3):241-3. PubMed ID: 9289883
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of neurofilament concentration in healthy adult horses and utility in the diagnosis of equine protozoal myeloencephalitis and equine motor neuron disease.
    Morales Gómez AM; Zhu S; Palmer S; Olsen E; Ness SL; Divers TJ; Bischoff K; Mohammed HO
    Res Vet Sci; 2019 Aug; 125():1-6. PubMed ID: 31103855
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Previously Identified Genetic Variants in
    Marquardt SA; Wilcox CV; Burns EN; Peterson JA; Finno CJ
    Genes (Basel); 2019 Sep; 10(9):. PubMed ID: 31491999
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.